Zobrazeno 1 - 10
of 19
pro vyhledávání: '"O I Bydanov"'
Autor:
Y Y DYAKONOVA, O I BYDANOV, A M POPOV, Y V OLSHANSKAYA, E G BOICHENKO, O V ALEYNIKOVA, M A MASCHAN, L N SHELIKHOVA, D V LITVINOV, L A KHACHATRYAN, N I PONOMAREVA, L G FECHINA, G A NOVICHKOVA, E D PASHANOV, A I KARACHUNSKIY
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 37-50 (2018)
Aim. The analysis of experience of nelarabine use in refractory/relapsed T-cell acute lymphoblastic leukemia (T-ALL) depending on the immunophenotype and the line of therapy. Materials and methods. All the patients with relapsed or refractory T-ALL a
Externí odkaz:
https://doaj.org/article/8277c105b38f465fa2bd4074aac1eb65
Autor:
A I Karachunsky, Yu V Rumyantseva, S N Lagoiko, C Bührer, G Tallen, O V Aleinikova, O I Bydanov, N V Korepanova, L V Baidun, T V Nasedkina, A Von Stackelberg, G A Novichkova, A A Maschan, D V Litvinov, N I Ponomareva, K L Kondratchik, E G Mansurova, L G Fechina, O V Streneva, N B Yudina, G R Sharapova, A V Shamardina, I E Gerbek, A P Shapochnik, A G Rumyantsev, G Henze
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 41-50 (2015)
Aim. To determine predictors for decision-making on a differential approach to choosing glucocorticosteroids (GCS) for children and adolescents with acute lymphoblastic leukemia (ALL). Subjects and methods. The analysis covered 1064 primary patients
Externí odkaz:
https://doaj.org/article/147f5ec7da0240dfa743df8a897f13a9
Autor:
L. A. Vavilova, Yu. Yu. Dyakonova, O. I. Bydanov, N. V. Myakova, Yu. G. Abugova, L. Kh. Anderzhanova, D. A. Evstratov, E. E. Kurnikova, A. M. Popov, Yu. V. Olshanskaya, M. A. Maschan, L. N. Shelikhova, D. V. Litvinov, A. V. Popa, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:62-72
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. Despite remarkable improvements in the treatment of pediatric acute lymphoblastic leukemia over last years, relapse still carries a poor prognosis with considerable morbidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ed935a04ba533aa4121b7f0900658cc
https://doi.org/10.24287/1726-1708-2023-22-1-62-72
https://doi.org/10.24287/1726-1708-2023-22-1-62-72
Autor:
A. S. Slinin, O. I. Bydanov
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:169-177
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a2547088cb71f6addc7d08be6878647
https://doi.org/10.24287/1726-1708-2022-21-4-169-177
https://doi.org/10.24287/1726-1708-2022-21-4-169-177
Autor:
R. N. Suprun, Yu. V. Rumyantseva, O. I. Bydanov, L. I. Zharikova, S. N. Lagoiko, V. V. Lebedev, K. L. Kondratchik, E. A. Druy, E. G. Mansurova, T. V. Asekretova, O. E. Murashkina, O. V. Aleynikova, L. G. Fechina, G. V. Bykova, N. I. Ponomareva, N. V. Myakova, A. M. Popov, Yu. V. Olshanskaya, A. N. Kazakova, D. V. Litvinov, G. A. Novichkova, A. I. Karachunskiy
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:12-31
Introduction. Down syndrome (DS) is one of the most common chromosomal abnormalities. Children with DS have an increased risk of developing acute lymphoblastic leukemia (ALL). Standard therapy is usually used to treat ALL in children with Down syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f036e3dafc5f4f57b9d14b9e3cca4c8c
https://doi.org/10.21682/2311-1267-2022-9-3-12-31
https://doi.org/10.21682/2311-1267-2022-9-3-12-31
Autor:
D. V. Litvinov, N. V. Myakova, O. V. Aleynikova, L. G. Fechina, L. M. Minkina, K. L. Kondratchik, E. V. Inyushkina, K. S. Aslanyan, O. V. Ryskal, L. I. Zharikova, O. I. Bydanov, S. N. Lagoyko, Yu. V. Rumyantseva, G. A. Novichkova, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:28-41
This paper presents the results for the patients with acute lymphoblastic leukemia (ALL) from the high-risk group (HRG) treated according to the ALL-MB 2002 Protocol. The registration phase of the study was performed from 15.04.2002 to 01.01.2008. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a33a652fa2728f61812551b22b106d89
https://doi.org/10.24287/1726-1708-2022-21-3-28-41
https://doi.org/10.24287/1726-1708-2022-21-3-28-41
Publikováno v:
Proceedings of the National Academy of Sciences of Belarus, Medical series. 19:240-247
Cerebrovascular disease represents a threatening factor for brain cancer survivors. However, a comprehensive evaluation of small vessel disease related to gliomas has not yet been performed. This study aims to characterize concomitant vascular lesion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7d9296ebb1880b8c3a09b1d6060e397
https://doi.org/10.29235/1814-6023-2022-19-2-240-247
https://doi.org/10.29235/1814-6023-2022-19-2-240-247
Publikováno v:
Informatika, Vol 0, Iss 4, Pp 75-84 (2016)
The robust version of the spatial scanning statistics for clustering is proposed. Spatio-temporal cluster analysis algorithms were used for the cluster detection of incidence of thyroid carcinoma. Me-thods and algorithms of detection and building clu
Externí odkaz:
https://doaj.org/article/9dd8b33f61254db3ac8cd868217e1c8b
Long-term outcome and surrogate molecular signatures of pediatric patients with diffuse astrocytomas
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 20:69-77
Diffuse astrocytomas is the major cause of mortality in pediatric neurooncology. Pediatric diffuse astrocytomas are clinically and biologically heterogeneous, they consist of distinct subtypes driven by various molecular events. Our aim was to reveal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f84e90153080c751195ccda74dcd9f88
https://doi.org/10.24287/1726-1708-2021-20-4-69-77
https://doi.org/10.24287/1726-1708-2021-20-4-69-77
Autor:
Olga Soldatkina, O. I. Bydanov, A. A. Chervova, E. N. Nikitin, S. N. Lagoyko, Elena Zerkalenkova, Yu. V. Rumyantseva, Alexander Popov, Y Olshanskaya, N. M. Timofeyeva, L. I. Zharikova, A. I. Karachunskiy, Anna Kazakova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 20:97-110
The detection of genetic markers associated with poor prognosis is crucial to the selection of an appropriate treatment plan for B-cell precursor acute lymphoblastic leukemia (BCP-ALL). A hypodiploid karyotype in patients with BCP-ALL has an unfavora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8ebc31353dcac342858bacec1e26879
https://doi.org/10.24287/1726-1708-2021-20-2-97-110
https://doi.org/10.24287/1726-1708-2021-20-2-97-110